The FDA has approved Novavax’s Nuvaxovid, a non-mRNA COVID vaccine aimed at adults 65 and high-risk individuals aged 12-64. Although the approval is limited, many people qualify due to underlying conditions. Nuvaxovid offers an effective alternative, with simpler storage and fewer side effects compared to other vaccines.
The Novavax COVID Vaccine Has Been Approved Read More »
Some people believe Paxlovid does little for COVID, but they leave out vital information. The EPIC-HR study showed Paxlovid’s high effectiveness for high-risk patients, but the EPID-SR study found it no better than placebo for standard-risk patients. It’s crucial to consider both studies before forming an opinion on Paxlovid’s efficacy.
Does Paxlovid Do Little Or Nothing for COVID? Read More »
Many individuals who received and spread misinformation about COVID and vaccines have suffered harm and death. Anti-vaccine activists, including religious leaders and media personalities, succumbed to COVID despite discouraging vaccinations and masks. The common thread linking these tragedies is exposure to misinformation and the influence of prominent figures promoting false information.
How Many People Have Died After Listening to Bad Advice About COVID? Read More »
Everyone who is at least 6 months old should get an updated COVID vaccine to help reduce their risk of serious COVID infections.
What to Know About the Updated COVID Vaccines Read More »
You must be logged in to post a comment.